Where You Live May Impact Use of Unnecessary Imaging

This article originally appeared here.
Share this content:
Where You Live May Impact Use of Unnecessary Imaging
Where You Live May Impact Use of Unnecessary Imaging

FRIDAY, March 13, 2015 (HealthDay News) -- Patients with low-risk prostate or breast cancer may have higher or lower odds of getting an unnecessary imaging based on geography, according to a new study published online March 12 in JAMA Oncology.

The study was led by Danil Makarov, M.D., M.H.S., of the NYU Langone Medical Center in New York City. His team examined the 2004 to 2007 medical records of 9,219 men with low-risk prostate cancer and 30,398 women with low-risk breast cancer. All were treated at one of 84 different hospital referral regions across the country.

Overuse of medical imaging occurred among 44.4 percent of the men and 41.8 percent of the women, the researchers found. However, there were notable differences between regions, with higher rates in the Northeast, and lower rates in the Northwest and Utah.

"These findings challenge us to move in a different direction than focusing exclusively on individual patient/doctor decision making," Makarov, assistant professor of urology, population health, and health policy at NYU Langone, said in a center news release. Policy makers should target areas where imaging is overused and "promote incentives for appropriate care," he said. "Such a focus would enhance efforts to cut excessive health spending."

Abstract
Full Text
Editorial

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »